posted on 2015-07-14, 11:43authored byP. Proitsi, M. K. Lupton, L. Velayudhan, S. Newhouse, I. Fogh, M. Tsolaki, M. Daniilidou, M. Pritchard, I. Kloszewska, H. Soininen, P. Mecocci, B. Vellas, Alzheimer's Disease Neuroimaging Initiative, J. Williams, GERAD1 Consortium, R. Stewart, P. Sham, S. Lovestone, J. F. Powell
Although altered lipid metabolism has been extensively implicated in the pathogenesis of Alzheimer disease (AD) through cell biological, epidemiological, and genetic studies, the molecular mechanisms linking cholesterol and AD pathology are still not well understood and contradictory results have been reported. We have used a Mendelian randomization approach to dissect the causal nature of the association between circulating lipid levels and late onset AD (LOAD) and test the hypothesis that genetically raised lipid levels increase the risk of LOAD.
History
Citation
PLoS Medicine, 2014, 11 (9), e1001713
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Health Sciences